- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02093481
Effects of Dietary Fibre on Glucose Metabolism and Satiety
June 25, 2014 updated by: Jonna Sandberg, Lund University
Intrinsic Indigestible Carbohydrates as Means to Modulate Colonic Events, With Specific Focus on Metabolism and Satiety
The experimental model is a semi-acute study where the purpose of the study is to evaluate food factors related to colonially derived regulation of glucose metabolism (and related parameters) and satiety in healthy subjects.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
19
Phase
- Early Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
SE
-
Lund, SE, Sweden, 221 00
- Applied Nutrition and Food Chemistry, Lund Univeristy
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 35 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Normal fasting blood glucose, BMI 19-25 kg/m2
Exclusion Criteria:
- Gastrointestinal diseases or food allergies e.g. lactose-, gluten intolerance, metabolic disorders e.g. diabetes, tobacco/snuff users. Antibiotic or probiotic usage within two weeks, and during study. Vegetarians.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: + ind. CHO + prim
Test meal: ate intrinsic indigestible carbohydrates 3 days prior to measurements of variables (priming)
|
The reference or test meal was eaten 3 days prior to measurements of variables.
|
|
Experimental: - ind. CHO + prim
Reference:ate no intrinsic indigestible carbohydrates 3 days prior to measurements of variables (priming)
|
The reference or test meal was eaten 3 days prior to measurements of variables.
|
|
Experimental: + ind. CHO - prim
Test meal: ate intrinsic indigestible carbohydrates 1 day prior to measurements of variables (no priming)
|
The reference or test meal was eaten 1 days prior to measurements of variables.
|
|
Experimental: - ind. CHO - prim
Reference: ate no indigestible carbohydrates the day prior to measurements of variables (no priming).
|
The reference or test meal was eaten 1 days prior to measurements of variables.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood glucose
Time Frame: Postprandial 0-180 min after breakfast
|
The test products are both ingested one day and three days prior to measurements of variables.
|
Postprandial 0-180 min after breakfast
|
|
Insulin
Time Frame: Postprandial 0-180 min after breakfast
|
The test products are both ingested one day and three days prior to measurements of variables.
|
Postprandial 0-180 min after breakfast
|
|
Appetite hormones
Time Frame: Postprandial 0-180 min after breakfast
|
The test products are both ingested one day and three days prior to measurements of variables.
|
Postprandial 0-180 min after breakfast
|
|
Markers of colonic fermentation and inflammation
Time Frame: Postprandial 0-180 min after breakfast
|
The test products are both ingested one day and three days prior to measurements of variables.
|
Postprandial 0-180 min after breakfast
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subjective satiety
Time Frame: Postprandial 0-180 min after breakfast
|
The measures of hunger, satiety, and desire to eat with the use of a VAS were determined every hour throughout the postprandial testing sessions.
|
Postprandial 0-180 min after breakfast
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Anne Nilsson, PhD, Lund Univeristy
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2014
Primary Completion (Actual)
June 1, 2014
Study Completion (Actual)
June 1, 2014
Study Registration Dates
First Submitted
March 10, 2014
First Submitted That Met QC Criteria
March 19, 2014
First Posted (Estimate)
March 21, 2014
Study Record Updates
Last Update Posted (Estimate)
June 26, 2014
Last Update Submitted That Met QC Criteria
June 25, 2014
Last Verified
June 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Dnr2013/241
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
Clinical Trials on Test meal
-
Federico II UniversityCompleted
-
Laval UniversityCompleted
-
Swiss Federal Institute of TechnologyUnknownIron-deficiencySwitzerland
-
Federico II UniversityCompleted
-
Clinical Nutrition Research Center, Illinois Institute...CompletedGlycemic ResponseUnited States
-
University of NottinghamUnilever R&DCompleted
-
Swiss Federal Institute of TechnologyUnknownIron-deficiencySwitzerland
-
National Institute of Diabetes and Digestive and...RecruitingObesity | Healthy VolunteerUnited States
-
Pennington Biomedical Research CenterRecruitingEnergy Expenditure | Metabolism | Metabolic Flexibility | Infant Formula | Human Milk, Breast Milk | Infant Body Composition and MetabolismUnited States
-
Oxford Brookes UniversityCompleted